We're not solely dependent on them. And as I pointed out, there are over 30 countries that have the CAMR system. I don't think India will run into that limit, but let me assume you're right. If they do run into a limit, there are 27 countries in the European Union that can pick up the slack. There's Switzerland, which has an enormous pharmaceutical industry—little Switzerland has a much bigger pharmaceutical industry than we have in Canada; there is Norway; there is China. So we're not really short on countries having CAMR-like laws that could invoke them.
May I add one other thing? I want to respond to some of what was said. You know that you're doing well in an argument when people put words in your mouth. I'm very distressed to see Professor Abbott very untruthfully say that I called Canadian generics "incompetent". I did not.